Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-058821)

Filing Details

Accession Number:: 0001209191-18-058821
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-15 19:06:53
Reporting Period:: 2018-11-15

Accepted Time:: 2018-11-15 19:06:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1710340	Eton Pharmaceuticals Inc.	ETON	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1274282	L Mark Baum	C/O Eton Pharmaceuticals, Inc. 21925 W Field Parkway, Suite 235 Deer Park IL 60010		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-11-15	10,000	$6.00	10,000	No	4	P	Indirect	by Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	by Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	784,745	Direct